Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

Study Identifier
GMA-OZU-09-011
CT.gov Identifier
NCT01411696
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone intravitreal implant 0.7 mg
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Macular edema * Received at least 2 OZURDEX® injections
    Exclusion Criteria:
    * Received OZURDEX® injections as part of a clinical study

    Protocol Summary

    This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.

    Study Locations

    Location
    Status
    Location
    San Antonio, Texas, United States
    Status
    Not applicable